Clinical Trial Update: Nonacog Alfa Prophylaxis And Treatment Of Bleeding Episodes In Previously Treated Patients With Hemophilia B [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating nonacog alfa for prophylaxis and treatment of bleeding episodes in previously treated patients with Hemophilia B has completed w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• Nonacog alfa (nonacog alfa)

Snippet

Sponsor: Pfizer | Conditions: Hemophilia B | Phase 4 | Status: COMPLETED | Results posted: 2021-07-30